In particular, this study uncovers an autoinhibitory mechanism of ALAS2 mediated by its Ct-extension, providing the framework to explain how frameshift indel mutations in the ALAS2 C-terminus lead to the gain-of-function disorder XLP. Here, ALAS2 is linked to X-linked lymphoproliferative disease.